The group of repebodies with a broad range of affinities were expected to be ideal for investigating the affinity-based differences in tumor localization (with the uncontrolled variables excluded) because they shared a strong sequence identity (>95%) (Lee et al., 2015) and bound a common epitope on EGFR (Figure S2). This evidence concerns the gene EGFR and neoplasm.